nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0347	CcSEcCtD
Gemcitabine—CMPK1—hindbrain—amyotrophic lateral sclerosis	0.0164	0.0837	CbGeAlD
Gemcitabine—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0299	CcSEcCtD
Gemcitabine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0135	0.028	CcSEcCtD
Gemcitabine—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0251	CcSEcCtD
Gemcitabine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0238	CcSEcCtD
Gemcitabine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0232	CcSEcCtD
Gemcitabine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0216	CcSEcCtD
Gemcitabine—POLE—embryo—amyotrophic lateral sclerosis	0.0096	0.0491	CbGeAlD
Gemcitabine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00951	0.0197	CcSEcCtD
Gemcitabine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00945	0.0195	CcSEcCtD
Gemcitabine—CMPK1—brainstem—amyotrophic lateral sclerosis	0.00939	0.048	CbGeAlD
Gemcitabine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00908	0.0188	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00908	0.0188	CcSEcCtD
Gemcitabine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00875	0.0181	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00859	0.0178	CcSEcCtD
Gemcitabine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00854	0.0177	CcSEcCtD
Gemcitabine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00816	0.0169	CcSEcCtD
Gemcitabine—RRM2—embryo—amyotrophic lateral sclerosis	0.00791	0.0404	CbGeAlD
Gemcitabine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00765	0.0158	CcSEcCtD
Gemcitabine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0154	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00717	0.0148	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00714	0.0148	CcSEcCtD
Gemcitabine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00697	0.0144	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0142	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0133	CcSEcCtD
Gemcitabine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00639	0.0132	CcSEcCtD
Gemcitabine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0125	CcSEcCtD
Gemcitabine—CMPK1—spinal cord—amyotrophic lateral sclerosis	0.00584	0.0298	CbGeAlD
Gemcitabine—POLD1—cerebellum—amyotrophic lateral sclerosis	0.0058	0.0297	CbGeAlD
Gemcitabine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00576	0.0119	CcSEcCtD
Gemcitabine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0117	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00562	0.0116	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0114	CcSEcCtD
Gemcitabine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00539	0.0111	CcSEcCtD
Gemcitabine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0106	CcSEcCtD
Gemcitabine—DCK—embryo—amyotrophic lateral sclerosis	0.0051	0.0261	CbGeAlD
Gemcitabine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0104	CcSEcCtD
Gemcitabine—CMPK1—nervous system—amyotrophic lateral sclerosis	0.00492	0.0251	CbGeAlD
Gemcitabine—SLC29A2—cerebellum—amyotrophic lateral sclerosis	0.00487	0.0249	CbGeAlD
Gemcitabine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00483	0.01	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0098	CcSEcCtD
Gemcitabine—CMPK1—central nervous system—amyotrophic lateral sclerosis	0.00474	0.0242	CbGeAlD
Gemcitabine—POLD1—brain—amyotrophic lateral sclerosis	0.00471	0.0241	CbGeAlD
Gemcitabine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00974	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00974	CcSEcCtD
Gemcitabine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00969	CcSEcCtD
Gemcitabine—CMPK1—cerebellum—amyotrophic lateral sclerosis	0.00463	0.0237	CbGeAlD
Gemcitabine—POLE—nervous system—amyotrophic lateral sclerosis	0.00461	0.0236	CbGeAlD
Gemcitabine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00953	CcSEcCtD
Gemcitabine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00948	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0094	CcSEcCtD
Gemcitabine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00928	CcSEcCtD
Gemcitabine—POLE—central nervous system—amyotrophic lateral sclerosis	0.00444	0.0227	CbGeAlD
Gemcitabine—POLE—cerebellum—amyotrophic lateral sclerosis	0.00434	0.0222	CbGeAlD
Gemcitabine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00434	0.00897	CcSEcCtD
Gemcitabine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00895	CcSEcCtD
Gemcitabine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00892	CcSEcCtD
Gemcitabine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00886	CcSEcCtD
Gemcitabine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00881	CcSEcCtD
Gemcitabine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00879	CcSEcCtD
Gemcitabine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00877	CcSEcCtD
Gemcitabine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00875	CcSEcCtD
Gemcitabine—RRM1—medulla oblongata—amyotrophic lateral sclerosis	0.0042	0.0215	CbGeAlD
Gemcitabine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00844	CcSEcCtD
Gemcitabine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.004	0.00828	CcSEcCtD
Gemcitabine—SLC29A2—brain—amyotrophic lateral sclerosis	0.00395	0.0202	CbGeAlD
Gemcitabine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0081	CcSEcCtD
Gemcitabine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00806	CcSEcCtD
Gemcitabine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00804	CcSEcCtD
Gemcitabine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00801	CcSEcCtD
Gemcitabine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00797	CcSEcCtD
Gemcitabine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00789	CcSEcCtD
Gemcitabine—RRM2—nervous system—amyotrophic lateral sclerosis	0.0038	0.0194	CbGeAlD
Gemcitabine—CMPK1—brain—amyotrophic lateral sclerosis	0.00376	0.0192	CbGeAlD
Gemcitabine—RRM1—spinal cord—amyotrophic lateral sclerosis	0.00374	0.0191	CbGeAlD
Gemcitabine—POLA1—cerebellum—amyotrophic lateral sclerosis	0.00374	0.0191	CbGeAlD
Gemcitabine—RRM2—central nervous system—amyotrophic lateral sclerosis	0.00366	0.0187	CbGeAlD
Gemcitabine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00751	CcSEcCtD
Gemcitabine—POLE—brain—amyotrophic lateral sclerosis	0.00352	0.018	CbGeAlD
Gemcitabine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00721	CcSEcCtD
Gemcitabine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00718	CcSEcCtD
Gemcitabine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00701	CcSEcCtD
Gemcitabine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00695	CcSEcCtD
Gemcitabine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00678	CcSEcCtD
Gemcitabine—DCK—medulla oblongata—amyotrophic lateral sclerosis	0.00326	0.0167	CbGeAlD
Gemcitabine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00671	CcSEcCtD
Gemcitabine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00661	CcSEcCtD
Gemcitabine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00661	CcSEcCtD
Gemcitabine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00661	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00657	CcSEcCtD
Gemcitabine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00653	CcSEcCtD
Gemcitabine—RRM1—nervous system—amyotrophic lateral sclerosis	0.00315	0.0161	CbGeAlD
Gemcitabine—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.00311	0.0159	CbGeAlD
Gemcitabine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00634	CcSEcCtD
Gemcitabine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00634	CcSEcCtD
Gemcitabine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0063	CcSEcCtD
Gemcitabine—POLA1—brain—amyotrophic lateral sclerosis	0.00304	0.0155	CbGeAlD
Gemcitabine—RRM1—central nervous system—amyotrophic lateral sclerosis	0.00304	0.0155	CbGeAlD
Gemcitabine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00622	CcSEcCtD
Gemcitabine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.003	0.00621	CcSEcCtD
Gemcitabine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00616	CcSEcCtD
Gemcitabine—RRM1—cerebellum—amyotrophic lateral sclerosis	0.00297	0.0152	CbGeAlD
Gemcitabine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00613	CcSEcCtD
Gemcitabine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00604	CcSEcCtD
Gemcitabine—DCK—spinal cord—amyotrophic lateral sclerosis	0.00291	0.0149	CbGeAlD
Gemcitabine—RRM2—brain—amyotrophic lateral sclerosis	0.0029	0.0148	CbGeAlD
Gemcitabine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00592	CcSEcCtD
Gemcitabine—TYMS—nervous system—amyotrophic lateral sclerosis	0.00286	0.0146	CbGeAlD
Gemcitabine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00578	CcSEcCtD
Gemcitabine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00573	CcSEcCtD
Gemcitabine—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.00277	0.0142	CbGeAlD
Gemcitabine—TYMS—central nervous system—amyotrophic lateral sclerosis	0.00275	0.0141	CbGeAlD
Gemcitabine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00569	CcSEcCtD
Gemcitabine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00565	CcSEcCtD
Gemcitabine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00564	CcSEcCtD
Gemcitabine—TYMS—cerebellum—amyotrophic lateral sclerosis	0.00269	0.0138	CbGeAlD
Gemcitabine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00551	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00547	CcSEcCtD
Gemcitabine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00547	CcSEcCtD
Gemcitabine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00542	CcSEcCtD
Gemcitabine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00542	CcSEcCtD
Gemcitabine—SLC29A1—nervous system—amyotrophic lateral sclerosis	0.00256	0.0131	CbGeAlD
Gemcitabine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00522	CcSEcCtD
Gemcitabine—SLC29A1—central nervous system—amyotrophic lateral sclerosis	0.00247	0.0126	CbGeAlD
Gemcitabine—DCK—nervous system—amyotrophic lateral sclerosis	0.00245	0.0125	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00243	0.00758	CbGpPWpGaD
Gemcitabine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00501	CcSEcCtD
Gemcitabine—SLC29A1—cerebellum—amyotrophic lateral sclerosis	0.00241	0.0123	CbGeAlD
Gemcitabine—RRM1—brain—amyotrophic lateral sclerosis	0.00241	0.0123	CbGeAlD
Gemcitabine—DCK—central nervous system—amyotrophic lateral sclerosis	0.00236	0.0121	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00235	0.00733	CbGpPWpGaD
Gemcitabine—DCK—cerebellum—amyotrophic lateral sclerosis	0.00231	0.0118	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00226	0.00705	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00226	0.00705	CbGpPWpGaD
Gemcitabine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00455	CcSEcCtD
Gemcitabine—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.0022	0.0112	CbGeAlD
Gemcitabine—TYMS—brain—amyotrophic lateral sclerosis	0.00219	0.0112	CbGeAlD
Gemcitabine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00449	CcSEcCtD
Gemcitabine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00434	CcSEcCtD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00207	0.00644	CbGpPWpGaD
Gemcitabine—SLC29A1—brain—amyotrophic lateral sclerosis	0.00196	0.01	CbGeAlD
Gemcitabine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00403	CcSEcCtD
Gemcitabine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00193	0.004	CcSEcCtD
Gemcitabine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00399	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00192	0.00599	CbGpPWpGaD
Gemcitabine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00397	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00192	0.00598	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00192	0.00598	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00192	0.00598	CbGpPWpGaD
Gemcitabine—DCK—brain—amyotrophic lateral sclerosis	0.00187	0.00957	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00184	0.00574	CbGpPWpGaD
Gemcitabine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00377	CcSEcCtD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00179	0.00557	CbGpPWpGaD
Gemcitabine—ABCC10—brain—amyotrophic lateral sclerosis	0.00178	0.00912	CbGeAlD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00178	0.00556	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00175	0.00547	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00175	0.00546	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00174	0.00544	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00171	0.00534	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00169	0.00528	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00169	0.00525	CbGpPWpGaD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00168	0.00524	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00168	0.00523	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00168	0.00522	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00163	0.00508	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00159	0.00497	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00153	0.00478	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00152	0.00472	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00143	0.00447	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00143	0.00445	CbGpPWpGaD
Gemcitabine—ABCB1—embryo—amyotrophic lateral sclerosis	0.0014	0.00717	CbGeAlD
Gemcitabine—CMPK1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00139	0.00432	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00137	0.00427	CbGpPWpGaD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00135	0.00422	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00133	0.00414	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00129	0.00402	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00129	0.00402	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00128	0.00398	CbGpPWpGaD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00124	0.00386	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00124	0.00385	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00123	0.00384	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00119	0.00369	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00119	0.00369	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00115	0.00358	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00115	0.00358	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00111	0.00347	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00108	0.00338	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00337	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00105	0.00328	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00105	0.00327	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00105	0.00327	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00104	0.00323	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00101	0.00315	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00101	0.00315	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00101	0.00314	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00101	0.00313	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00101	0.00313	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00099	0.00309	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000983	0.00306	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000977	0.00304	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000977	0.00304	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000971	0.00303	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000971	0.00303	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00097	0.00302	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000953	0.00297	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000947	0.00295	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000941	0.00293	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000936	0.00292	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000918	0.00286	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000918	0.00286	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000913	0.00285	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000904	0.00282	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000904	0.00282	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000899	0.0028	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000899	0.0028	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000898	0.0028	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000898	0.0028	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000897	0.0028	CbGpPWpGaD
Gemcitabine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000897	0.00458	CbGeAlD
Gemcitabine—TYMS—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000877	0.00273	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000871	0.00271	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000868	0.00271	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000868	0.00271	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.00086	0.00268	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00086	0.00268	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000857	0.00267	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000856	0.00267	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000855	0.00266	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000825	0.00257	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000821	0.00256	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000819	0.00255	CbGpPWpGaD
Gemcitabine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.0008	0.00409	CbGeAlD
Gemcitabine—CMPK1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000797	0.00248	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000769	0.0024	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000764	0.00238	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000764	0.00238	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00074	0.0023	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00074	0.0023	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000738	0.0023	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000735	0.00229	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000735	0.00229	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000731	0.00228	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000728	0.00227	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000728	0.00227	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000718	0.00224	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000693	0.00216	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000692	0.00216	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000692	0.00216	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000691	0.00215	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000691	0.00215	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000676	0.00211	CbGpPWpGaD
Gemcitabine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000674	0.00344	CbGeAlD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000673	0.0021	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000672	0.0021	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000664	0.00207	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000663	0.00207	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000663	0.00207	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000649	0.00202	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000649	0.00202	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000649	0.00202	CbGpPWpGaD
Gemcitabine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000649	0.00332	CbGeAlD
Gemcitabine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000634	0.00324	CbGeAlD
Gemcitabine—DCK—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000632	0.00197	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000629	0.00196	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000625	0.00195	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000623	0.00194	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000619	0.00193	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000619	0.00193	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—amyotrophic lateral sclerosis	0.0006	0.00187	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000599	0.00187	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000593	0.00185	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000593	0.00185	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000591	0.00184	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000588	0.00183	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000588	0.00183	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000588	0.00183	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000584	0.00182	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000564	0.00176	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00056	0.00174	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000558	0.00174	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000558	0.00174	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000553	0.00172	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000535	0.00167	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000534	0.00167	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000531	0.00166	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000526	0.00164	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000518	0.00162	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000518	0.00161	CbGpPWpGaD
Gemcitabine—ABCB1—brain—amyotrophic lateral sclerosis	0.000515	0.00263	CbGeAlD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000513	0.0016	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000504	0.00157	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—DAO—amyotrophic lateral sclerosis	0.0005	0.00156	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000493	0.00154	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000492	0.00153	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000492	0.00153	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000485	0.00151	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000485	0.00151	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.00048	0.0015	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000454	0.00142	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000443	0.00138	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00044	0.00137	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000428	0.00133	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000422	0.00132	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000415	0.00129	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000412	0.00128	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000405	0.00126	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000403	0.00126	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000393	0.00123	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000387	0.00121	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000379	0.00118	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000379	0.00118	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000374	0.00117	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000373	0.00116	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000372	0.00116	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000363	0.00113	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000351	0.00109	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—DAO—amyotrophic lateral sclerosis	0.00035	0.00109	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSR—amyotrophic lateral sclerosis	0.000349	0.00109	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000336	0.00105	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000334	0.00104	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000332	0.00104	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000324	0.00101	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000315	0.00098	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000307	0.000957	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000305	0.000951	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000301	0.000939	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000295	0.00092	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000292	0.00091	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00029	0.000905	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000287	0.000894	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000282	0.000878	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00028	0.000872	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000266	0.000828	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000265	0.000827	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000264	0.000824	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000248	0.000772	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSR—amyotrophic lateral sclerosis	0.000245	0.000764	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000243	0.000757	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000242	0.000754	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000237	0.00074	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000222	0.000691	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000205	0.000639	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000201	0.000627	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.0002	0.000625	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOE—amyotrophic lateral sclerosis	0.0002	0.000623	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000187	0.000583	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000184	0.000574	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000179	0.000559	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000175	0.000545	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000173	0.000538	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000172	0.000537	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000171	0.000534	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000165	0.000514	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000165	0.000514	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000164	0.000511	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000156	0.000486	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000154	0.000481	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000152	0.000473	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000152	0.000472	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000151	0.00047	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00015	0.000466	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00015	0.000466	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000148	0.000462	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000142	0.000442	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000137	0.000427	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000137	0.000426	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000133	0.000413	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000133	0.000413	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000127	0.000396	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000125	0.000389	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000124	0.000387	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00012	0.000373	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000118	0.000369	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000118	0.000368	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000118	0.000367	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—amyotrophic lateral sclerosis	0.000117	0.000363	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000114	0.000354	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000112	0.000349	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000108	0.000337	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000108	0.000337	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000104	0.000324	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.94e-05	0.00031	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.3e-05	0.00029	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.63e-05	0.000269	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.55e-05	0.000267	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.5e-05	0.000265	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.19e-05	0.000255	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOE—amyotrophic lateral sclerosis	8.18e-05	0.000255	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—amyotrophic lateral sclerosis	8.1e-05	0.000253	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.99e-05	0.000249	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—amyotrophic lateral sclerosis	7.76e-05	0.000242	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	7.56e-05	0.000236	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.32e-05	0.000228	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.21e-05	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.6e-05	0.000175	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.53e-05	0.000172	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.34e-05	0.000104	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.07e-05	9.56e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.52e-05	7.86e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.73e-05	5.39e-05	CbGpPWpGaD
